STOCKHOLM, Sweden, April 23, 2003 (PRIMEZONE) -- Investor's (Other OTC:IVSBF) (Other OTC:IVSXF) net asset value on March 31, 2003 amounted to SEK 58,869 m. (SEK 77 per share), compared with SEK 62,869 m. (SEK 82 per share) on December 31, 2002.
The value of Investor's total assets was SEK 76,189 m. on March 31, 2003, as against SEK 79,227 m. at year-end 2002.
Net debt amounted to SEK 17,320 m. on March 31, 2003 (SEK 16,358 m. on December 31, 2002), corresponding to 23 percent of total assets (21). At the end of the period, cash and short-term investments totaled SEK 10,786 m. (5,361).
The value of Investor's Core Holdings declined SEK 3,984 m. during the first three months of the year. AstraZeneca accounted for SEK -1,474 m. of the decrease, Gambro for SEK -892 m., and Ericsson for SEK -852 m. The value of the holding in SEB increased by SEK 140 m.
The value of New Investments changed by SEK -29 m. during the period. Investments totaled SEK 326 m. and shares were sold for SEK 474 m.
The total return on Investor shares was -6 percent in the first three months of 2003, compared with a 2-percent positive return in the corresponding period of 2002.
For information: Lars Wedenborn, Chief Financial Officer +46 8 614 2141, +46 70 624 2141 lars.wedenborn@investorab.com Fredrik Lindgren, Vice President, Corporate Communications +46 8 614 2031, +46 70 624 2031 fredrik.lindgren@investorab.com Investor Relations Group: +46 8 614 2800 ir@investorab.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2003/04/23/20030423BIT00150/wkr0001.doc
The full report
http://www.waymaker.net/bitonline/2003/04/23/20030423BIT00150/wkr0002.pdf
The full report